High virus loads in naturally and experimentally SIVagm-infected African green monkeys

Virology

Volumn 283, Issue 2, 2001, Pages 324-331

  Holzammer, Silke ^a   Holznagel, Edgar ^a   Kaul, Artur ^a   Kurth, Reinhard ^a,b   Norley, Stephen ^a,b  

^a PAUL EHRLICH INSTITUT   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

AIDS; HIV; Natural host; Pathogenesis; SIVagm; Virus load

Indexed keywords

VIRUS RNA;

ARTICLE; CERCOPITHECIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS LOAD; VIRUS REPLICATION;

ANIMALIA; CERCOPITHECUS AETHIOPS;

EID: 0035837051     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.0870     Document Type: Article

References (29)

1. Species-specific diversity among simian immunodeficiency viruses from African green monkeys
2. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS
3. Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host
4. Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys
5. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection
6. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys
7. +T-lymphocytes of African green monkeys efficiently suppress SIVagm replication
8. Origin of HFV-1 in the chimpanzee Pan troglodytes troglodytes
9. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa
10. Quantitation of a lentivirus in its natural host: Simian immunodeficiency virus in African green monkeys
11. Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replication
12. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
13. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons
14. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
15. Detection of specific polymerase chain reaction product by utilizing the 5′ - - 3′ exonuclease activity of Thermus aquaticus DNA polymerase
16. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys
17. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy
18. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
19. CD4 and CD8 expressions in African green monkey helper T lymphocytes: Implication for resistance to SIV infection
20. Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys
21. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR
22. Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm)
23. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease
24. +lymphocytes
25. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection
26. A pathogenic threshold of virus load defined in simian immunodeficiency virus- or human immunodeficiency virus-infected macaques
27. Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates
28. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival
29. Viral dynamics in human immunodeficiency virus type 1 infection